Bo Kang, Kyungseon Choi, Huanhuan Yang, Chungsoo Kim, Harlan M. Krumholz, Yuan Lu. Persistent Gaps in Semaglutide and Tirzepatide Prescribing Among Adults With Class III Obesity Without Type 2 Diabetes. // Diabetes, Obesity and Metabolism. – 2026. – DOI: 10.1111/dom.71517. – URL: https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.71517?af=R
Bo Kang, Kyungseon Choi, Huanhuan Yang, Chungsoo Kim, Harlan M. Krumholz, & Yuan Lu (2026). Persistent Gaps in Semaglutide and Tirzepatide Prescribing Among Adults With Class III Obesity Without Type 2 Diabetes. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71517
Bo Kang, et al. “Persistent Gaps in Semaglutide and Tirzepatide Prescribing Among Adults With Class III Obesity Without Type 2 Diabetes.” Diabetes, Obesity and Metabolism, 2026. doi:10.1111/dom.71517.
@article{Kang2026,
title = {Persistent Gaps in Semaglutide and Tirzepatide Prescribing Among Adults With Class III Obesity Without Type 2 Diabetes},
author = {Kang, Bo and Choi, Kyungseon and Yang, Huanhuan and Kim, Chungsoo and Krumholz, Harlan M. and Lu, Yuan},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.71517},
url = {https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.71517?af=R}
}